| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 162.78B | 172.37B | 157.34B | 140.20B | 161.11B | 123.58B |
| Gross Profit | 16.44B | 18.44B | 16.55B | 15.55B | 16.88B | 13.53B |
| EBITDA | 5.77B | 7.24B | 6.11B | 6.08B | 7.17B | 4.50B |
| Net Income | 3.91B | 4.95B | 3.52B | 2.74B | 3.83B | 2.52B |
Balance Sheet | ||||||
| Total Assets | 80.00B | 91.04B | 84.05B | 78.88B | 78.60B | 72.81B |
| Cash, Cash Equivalents and Short-Term Investments | 8.18B | 9.68B | 9.36B | 8.79B | 8.89B | 9.31B |
| Total Debt | 19.87B | 20.18B | 24.26B | 24.14B | 26.99B | 24.60B |
| Total Liabilities | 40.20B | 45.04B | 43.50B | 40.51B | 44.35B | 42.12B |
| Stockholders Equity | 39.73B | 45.93B | 40.49B | 38.30B | 34.18B | 30.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.58B | 678.00M | 5.34B | -869.00M | 2.12B |
| Operating Cash Flow | 0.00 | 5.71B | 3.98B | 5.74B | -780.00M | 2.19B |
| Investing Cash Flow | 0.00 | 677.00M | -2.22B | -364.00M | -46.00M | -149.00M |
| Financing Cash Flow | 0.00 | -6.59B | -1.11B | -5.88B | 262.00M | -18.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥11.68B | 3.90 | ― | 1.23% | 49.34% | 151.38% | |
68 Neutral | ¥11.13B | 9.40 | ― | 3.70% | -3.86% | 26.92% | |
67 Neutral | ¥26.76B | 14.10 | ― | 3.98% | 4.66% | ― | |
66 Neutral | ¥11.71B | 6.69 | 11.46% | 4.65% | 9.55% | 40.52% | |
65 Neutral | ¥12.90B | 27.31 | ― | 3.47% | -5.52% | 12.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
52 Neutral | ¥11.95B | -5.95 | ― | 1.86% | 11.06% | -804.16% |